To explore whether fibulin-5-induced FLJ10540 expression could affect cell migration and invasion in human NPC cells, we used siRNA to inhibit endogenous FLJ10540 expression and assayed the motility of fibulin-5-Hone1 and vehicle control cells. Here, FBLN5 is linked to nasopharyngeal carcinoma.